Simplicity Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Simplicity Wealth's BMY Position: Q1 2026 in Review
Simplicity Wealth increased its Bristol-Myers Squibb (BMY) stake by 26% in Q1 2026, buying an estimated $136K and bringing the position to 11,504 shares worth $698K. The position accounts for 0.04% of the portfolio, ranked #370.
Simplicity Wealth first reported a position in BMY in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.43M in Q1 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Simplicity Wealth held 11,504 shares of Bristol-Myers Squibb worth $698K as of Q1 2026.
- Simplicity Wealth bought 2,340 Bristol-Myers Squibb shares in Q1 2026, an estimated $136K.
- Bristol-Myers Squibb made up 0.04% of Simplicity Wealth's portfolio in Q1 2026, its #370 holding.
- Simplicity Wealth first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 7 quarters since.
- Simplicity Wealth's Bristol-Myers Squibb position peaked at $3.43M in Q1 2024.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Simplicity Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.